Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine ...

Llenacapavir, a new HIV prevention injection, has been shown to have a 96% efficacy rate against the spread of the virus.

Lenacapavir, a bi-annual injectable treatment for HIV prevention (PrEP), is being celebrated as a major advancement in the ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...

Experts at the François-Xavier Bagnoud Center at the Rutgers School of Nursing discuss how PrEP medication can help lower HIV infectionsPeople at risk ...

5 Despite this, Australia remains well short of its strategic goal of a 90% reduction in transmission from the 2010 baseline. 5 Progress towards HIV prevention targets faces at least two major ...

recognising that repeated exposure to messaging on PrEP (a medication used to significantly reduce the risk of contracting HIV), can have a huge effect in the long term. Grindr's frequent pop-up ...

Dr. Sharon Lewin, Professor of Medicine at Doherty Institute at the University of Melbourne, Australia joins The Excerpt to discuss why, in the 40 years since the onset of the HIV pandemic ...

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from HPTN 091 ("I Am Study") at the HIVR4P 2024 conference in Lima, Peru. The study examined the acceptability and ...